Business Wire

EDF Renewables and Shell Invest in New Jersey Offshore Wind

Jaa

EDF Renewables North America and Shell New Energies US LLC (Shell) announced today that they have formed a 50/50 joint venture, Atlantic Shores Offshore Wind, LLC to co-develop OCS-0499 lease area within the New Jersey Wind Energy Area (WEA). The lease area holds the potential to produce approximately 2,500 megawatts (MW) of offshore wind energy – enough to power close to one million homes. This transaction is subject to regulatory approvals. Construction is subject to positive final investment decision.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181219005737/en/

The lease comprises 183,353 acres about eight miles off the coast of Atlantic City on the U.S. Outer Continental Shelf (OCS). The area offers strong and steady wind resources in relatively shallow water, close to large population centers with associated electricity demand.

“Shell has bold ambitions to grow our renewable power business and we see great potential in U.S. offshore wind,” said Dorine Bosman, VP Shell Wind Development. “Gaining access to this acreage in New Jersey complements our successful entry to Massachusetts and our existing renewable generation business. Building on the strength of our brand and global presence allows us to continue providing our customers with more and cleaner energy.”

“The opportunity supports the EDF Group’s aim to double global renewable capacity to 50 gigawatts by 2030. It solidifies EDF Renewables' ambitions to leverage its depth of experience in the European offshore wind market in the emerging U.S. market,” commented Tristan Grimbert, President & CEO of EDF Renewables North America. “As the costs of offshore wind are declining, the U.S. offshore wind industry is quickly advancing with strong Federal and State support. The industry is well-positioned to meaningfully contribute to the New York and New Jersey economies through employment and supply chain opportunities.”

EDF Renewables already has 2,800 MW of offshore wind in development or operation in Europe (Belgium, France, Germany and United Kingdom), placing the company in a position to efficiently transform the U.S. offshore wind sector, beginning in New Jersey.

Shell first entered the onshore wind business in the U.S. in 2001. Shell has operated offshore assets for decades, has a strong supply-chain network and is one of the largest power wholesalers in North America. These strengths allow Shell to continue to grow its position in renewable power to support the company’s renewable power goals. Today Shell has interests in five operational onshore wind power projects in North America and one operational offshore wind farm in Europe. Shell is also part of a consortium that will build and operate the Borssele 3&4 wind farms in Europe.

Atlantic Shores Offshore Wind, LLC will begin working to complete a site assessment plan and initiate formal development efforts on the site, and subject to a positive final investment decision, could bring the wind farm into operation by the mid-2020s.

About EDF Renewables North America:

EDF Renewables North America is a market leading independent power producer and service provider with over 30 years of expertise in renewable energy. The Company delivers grid-scale power: wind (onshore and offshore), solar photovoltaic, and storage projects; distributed solutions: solar, solar+storage, EV charging and energy management; and asset optimization: technical, operational, and commercial skills to maximize performance of generating projects. EDF Renewables’ North American portfolio consists of 10 GW of developed projects and 10 GW under service contracts. EDF Renewables North America is a subsidiary of EDF Renewables, the dedicated renewable energy affiliate of the EDF Group. For more information visit: www.edf-re.com.

About EDF Renewables:

EDF Renewables is a leading international player in renewable energies, with gross installed capacity of 14.2 GW worldwide. Its development is mainly focused on wind and solar photovoltaic power but also in other areas of the renewable energies industry such as distributed energy and energy storage. EDF Renewables operates mostly in Europe and North America but is continuing to grow by moving into promising emerging regions such as Brazil, China, India, South Africa and the Gulf. The Company has strong positions in offshore wind power, totaling almost 2,800 MW including three projects along the French coastline with 1,500 MW in total capacity, and a 450 MW offshore wind project in the UK. EDF Renewables operates more than 800 MW of offshore wind capacity with three projects: C-Power (325 MW) in Belgium, Teesside (62 MW) and Blyth (41.5 MW) in the UK, and the operations and maintenance of 400 MW of offshore wind capacity with the recent acquisition of a company specialized in this activity based out of Germany. EDF Renewables develops, builds, operates and maintains renewable energies projects, both for itself and for third parties. Most of its international subsidiaries bear the EDF Renewables brand. EDF Renewables is the EDF Group subsidiary specialising in developing solar and wind power.

For more information, visit: www.edf-renewables.com.

Follow us on LinkedIn: https://www.linkedin.com/company/edf-renewables and on Twitter (@EDF_RE in French and @EDF_Renewables in English).

About Shell New Energies

Shell aims to make electricity a significant part of its business, from generating it to buying, selling and supplying electricity directly to customers. Our New Energies business is seeking to leverage the company’s strengths in fast-growing and commercial parts of the energy industry, such as offshore wind in the U.S.

Shell first entered the onshore wind business in the U.S. in 2001. Today, we have interests in five onshore wind power projects in North America and one offshore wind farm in Europe. In total, our share of the energy capacity from these projects is more than 400 megawatts (MW). Shell also has a 20% interest in the Blauwwind consortium that will build and operate the Borssele 3 and 4 wind farms off the Dutch coast. The wind farms are designed to have a total installed capacity of 731.5MW, enough to power around 825,000 Dutch households. Shell is a 50% shareholder in Mayflower Wind Energy LLC who is the provisional winner of block 0521 in Massachusetts, USA. Once constructed, the lease area in Massachusetts could accommodate a total generation capacity of approximately 1.6 gigawatts (GW), enough to power more than 680,000 homes with clean electricity each year.

https://www.shell.com/newenergies

Contact information

INQUIRIES:

EDF Renewables North America
Sandi Briner +1 858-521-3525
MediaRelations@edf-re.com

EDF Renewables
Manon de Cassini-Hérail +33 (0)1 40 90 48 22
manon.decassini-herail@edf-en.com

Shell Media Relations
Shell International +44 (0) 20 7934 5550
Shell U.S. +1 832 337 4355

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Fishawack continues to build best-in-class service offering with Dudnyk acquisition20.3.2019 16:00:00 EETTiedote

Fishawack, a leading independent healthcare communications specialist, is excited to announce its acquisition of Dudnyk, the Philadelphia-based healthcare communications agency. Dudnyk is an award-winning, full-service agency that specializes in creating insight-driven, authentic brand experiences that unite specialty physicians and their patients. They leverage strategic, scientific, and creative capabilities to serve clients in the biotech, pharmaceutical, and medical device industries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190320005204/en/ Dudnyk leadership team includes Christopher Tobias, PhD, President; Laurie Bartolomeo, EVP, Creative Director; Drew Desjardins, EVP, Chief Strategy Officer; Annemarie Armstrong, EVP, Director of Client Services; John Kemble, EVP, Creative Producer. (Photo: Business Wire) Fishawack’s goal is to increase the range of healthcare communications services that it can offer to commerc

ExaGrid Nominated in Six Categories for the 2019 Network Computing Awards20.3.2019 15:00:00 EETTiedote

ExaGrid ®, a leading provider of intelligent hyperconverged storage for backup, today announced that it has been nominated in six categories for the 2019 Network Computing Awards. ExaGrid has become a finalist for Data Centre Product of the Year, The Return on Investment Award, Hardware Product of the Year, Product of the Year, The Customer Service Award, and Company of the Year. Voting to determine the winner in each category is underway now and closes on April 23. The results will be revealed at an evening award ceremony in London on May 2. ExaGrid’s model EX63000E backup storage appliance with data deduplication is a nominee in four categories. The model provides the largest scale-out system and offers up to a 2PB full backup with an ingest rate of 432TB/hr, which is three times faster than any other backup storage on the market. “We are thrilled to be nominated by IT staff, and recognized by Network Computing, in six prestigious categories this year,” said Bill Andrews, CEO and Pre

Eos Biosciences Issued Patent for New Approach to Shuttle Therapeutics Across the Blood-Brain Barrier to Treat Brain Diseases20.3.2019 14:30:00 EETTiedote

Eos Biosciences, Inc. (Eos), a nanomedicines company developing an efficient and versatile nanobiologic particle-based platform technology (Eosomes), announced that the U.S. Patent and Trademark Office has granted Eos Biosciences Patent No. 10,183,078, relating to a novel approach of using HER3-targeted Eosomes as a shuttle system for transporting various classes of therapeutics across the blood-brain barrier for treatment of brain disorders, including brain cancer. The patent is owned by Cedars-Sinai Medical Center and is exclusively licensed to Eos Biosciences. Details of the system will be highlighted in an upcoming manuscript from Lali Medina-Kauwe, PhD, Professor, Department of Biomedical Sciences, Cedars-Sinai. Omar Haffar, Ph.D., Founder, President and Chief Executive Officer, commented, “We’re very excited by the issuance of this pivotal patent and look forward to receiving similar approvals in other countries. This patent adds to Eos’ considerable IP portfolio covering the Eos

Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics20.3.2019 13:45:00 EETTiedote

Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing gene therapy treatments for inherited liver disorders with high unmet medical need, and Pfizer Inc. (NYSE: PFE) announced today that Pfizer has acquired a 15% equity interest in Vivet and secured an exclusive option to acquire all outstanding shares. Pfizer and Vivet will collaborate on the development of VTX-801, Vivet’s proprietary treatment for Wilson disease. Wilson disease is a devastating, rare, chronic, and potentially life-threatening liver disorder of impaired copper transport that causes serious copper poisoning. In patients with Wilson disease, a monogenetic mutation disables the normal copper biliary excretion pathway leading to excess copper accumulation in the liver and other organs including the central nervous system. Untreated, Wilson disease results in various combinations and severity of hepatic (fibrosis and cirrhosis), neurologic and psychiatric symptoms, which can b

Fintech Company Rimilia Appoints Kevin Kimber as CEO20.3.2019 13:00:00 EETTiedote

Rimilia, a fintech company helping finance departments simplify the complex, has appointed Kevin Kimber as CEO. The news follows another strong year for Rimilia. In 2018, Rimilia opened offices in Central London and Denver, Colorado in the U.S., and reported significant revenue growth on the previous year. Rimilia was founded in 2008 and its platform, created by finance professionals, uses RPA (robotic process automation) technology to help finance teams fast-track their cash flow by providing clearer information and better control. It has quickly become the industry leader, trusted by a number of global brands from HSBC to DHL and Santander, to provide visibility, improve efficiencies and guarantee cash flow. Rimilia works with any currency, any bank and in any language, and on average delivers 70% cost-savings and an 80% reduction in manual effort to its customers. Kevin joins Rimilia from Eight Roads Ventures (one of Rimilia’s investors), where he was a Venture Partner, advising its

Knopp Biosciences Enters Collaboration with Leading UK Investigators to Commence Phase 2 Clinical Trial of Dexpramipexole in Severe Eosinophilic Asthma20.3.2019 13:00:00 EETTiedote

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases with high unmet need, today announced a collaboration with a consortium of leading medical researchers in the United Kingdom to evaluate the ability of Knopp’s lead drug candidate, dexpramipexole, to reduce exacerbations in people with severe eosinophilic asthma. The project is chiefly funded by the National Institute for Health Research (NIHR) and Medical Research Council (MRC) of the UK. The Chief Investigator for the Phase 2 multi-center, 52-week trial is Professor Salman Siddiqui, Professor of Airway Diseases at the University of Leicester and Consultant Respiratory Physician at Leicester’s Hospitals. Dexpramipexole is an orally available small molecule shown to selectively reduce eosinophil levels in multiple clinical trials, including in a Phase 2 study in hypereosinophilic syndrome (HES) and a Phase 2 trial in chr

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme